Korean Faculty
Do-Yoon Kang, MD
Asan Medical Center
Korea (Republic of)
Sessions
April 25 | 11:32 AM - 11:40 AM
Presentation Room 2, Level 1
Outcomes From the Bifurcation Subgroup of OCTIVUS Presentation Room 2, Level 1
Lecturer
April 25 | 12:02 PM - 12:10 PM
Presentation Room 1, Level 1
Current Status of Mitral -TEER in Korea : AMC Experience Presentation Room 1, Level 1
Lecturer
April 25 | 12:47 PM - 1:02 PM
Valve & Endovascular Theater, Level 2
AMC CT Algorithm for TAVR with SAPIEN 3 Platform Valve & Endovascular Theater, Level 2
Lecturer
April 25 | 3:10 PM - 3:18 PM
Valve & Endovascular Theater, Level 2
Case 2. Choosing Wisely: FFR vs. Anatomy-guided Left Main PCI -The Rationale of the FATE-MAIN Trial Valve & Endovascular Theater, Level 2
Lecturer
April 25 | 4:47 PM - 4:55 PM
Valve & Endovascular Theater, Level 2
Case 1. Mini-Crush for Bifurcation PCI Valve & Endovascular Theater, Level 2
Lecturer
April 25 | 5:22 PM - 5:30 PM
Presentation Room 1, Level 1
Real-World Data on Widespread Use of DCB: Insights From the IRIS-DEB Registry Presentation Room 1, Level 1
Lecturer
April 26 | 8:40 AM - 9:20 AM
Main Arena, Level 2
Asan Medical Center, Korea: Case #9 Main Arena, Level 2
1st Operator
April 26 | 3:00 PM - 3:50 PM
Valve & Endovascular Theater, Level 2
Asan Medical Center, Korea: Case #5 Valve & Endovascular Theater, Level 2
1st Operator
April 27 | 8:44 AM - 8:51 AM
Presentation Room 1, Level 1
OCTIVUS Trial: OCT- vs. IVUS-guided PCI in All-comer PCI Presentation Room 1, Level 1
Lecturer
April 27 | 9:38 AM - 9:46 AM
Main Arena, Level 2
Intravascular Imaging-guided Complex PCI: Which One and Why? Main Arena, Level 2
Lecturer
April 27 | 10:40 AM - 11:52 AM
Valve & Endovascular Theater, Level 2
Valve & Endovascular Theater, Level 2
Panelist
April 27 | 12:50 PM - 1:10 PM
Presentation Room 2, Level 1
Intensive Lipid-Lowering Therapy for Early Achievement of LDL-C Target in Cardiovascular Disease Presentation Room 2, Level 1
Lecturer